New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
BioAtla, Inc.
BCAB
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

94M

Biotechnology

Next Earning date - 05 Nov 2024

94M

Biotechnology

Next Earning date - 05 Nov 2024

1.94USD
Shape0.09 ( 4.86%)
favorite-chart

Relative Strenght

7
favorite-chart

Volume Buzz

-53%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

52%

Quote Panel

Shape
Updated October 19, 2024
1W -3.48 % 1M 12.79 % 3M 11.49 % 1Y 21.25 %

Key Metrics

Shape
  • Market Cap

    93.77M


  • Shares Outstanding

    48.34M


  • Share in Float

    39.01M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    1.94


  • Average Volume

    1.19M


  • Beta

    1.045


  • Range

    1.14-4.02


  • Industry

    Biotechnology


  • Website

    https://www.bioatla.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

54.97x

P/S Ratio

2.98x

P/B Ratio

0.1

Debt/Equity

-6128.7%

Net Margin

$-2.2

EPS

How BCAB compares to sector?

P/E Ratio

Relative Strength

Shape

BCAB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3M

ShapeNaN%

2025-Revenue

$1.49

Shape-238%

2025-EPS

$573K

Shape97%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.69
vs -0.68

Q4.22

arrow
arrow

N/A

-0.63
vs -0.63

Q1.23

arrow
arrow

N/A

-0.58
vs -0.65

Q2.23

arrow
arrow

N/A

-0.75
vs -0.77

Q3.23

arrow
arrow

N/A

-0.70
vs -0.69

Q4.23

arrow
arrow

N/A

-0.56
vs -0.63

Q1.24

arrow
arrow

N/A

-0.48
vs -0.58

Q2.24

arrow
arrow

N/A

-0.44
vs -0.75

Q3.24

arrow
arrow

N/A

-0.37
vs -0.70

Q4.24

arrow
arrow

N/A

-0.33
vs -0.56

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

-100%

NA  vs 250K

Q3.22

arrow
arrow

-100%

NA  vs 150K

Q4.22

arrow
arrow

-100%

NA  vs 250K

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

1.7M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-18%

-0.18
vs -0.17

Q4.22

arrow
arrow

-15%

-0.15
vs -0.18

Q1.23

arrow
arrow

-17%

-0.17
vs -0.15

Q2.23

arrow
arrow

-29%

-0.29
vs -0.17

Q3.23

arrow
arrow

-35%

-0.35
vs -0.29

Q4.23

arrow
arrow

-38%

-0.38
vs -0.35

Q1.24

arrow
arrow

-47%

-0.47
vs -0.38

Q2.24

arrow
arrow

-67%

-0.67
vs -0.47

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

74

74
vs 76

-3%

Q4.22

arrow
arrow

93

93
vs 74

26%

Q1.23

arrow
arrow

81

81
vs 93

-13%

Q2.23

arrow
arrow

88

88
vs 81

9%

Q3.23

arrow
arrow

83

83
vs 88

-6%

Q4.23

arrow
arrow

79

79
vs 83

-5%

Q1.24

arrow
arrow

88

88
vs 79

11%

Q2.24

arrow
arrow

81

81
vs 88

-8%

Earnings Growth

Latest News

BCAB

seekingalpha.com

11 hours ago